Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective a4B2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders
Mazurov, A., Miao, L., Bhatti, B., Strachan, J., Akireddy, S., Murthy, S., Kombo, D., Xiao, Y., Hammond, P., Zhang, J., Hauser, T., Jordan, K., Miller, C., Speake, J., Gatto, G., & Yohannes, D. (2012). Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective a4B2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders. Journal of Medicinal Chemistry, 55(22), 9793 - 9809.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.